| 1 | significant | 154,178 |
| 2 | significative | 65 |
| 3 | discernable | 43 |
| 4 | statistically-significant | 30 |
| 5 | signficant | 9 |
| 6 | genotype-related | 7 |
| 7 | doxycycline-mediated | 5 |
| 8 | borderline-significant | 4 |
| 9 | sigificant | 4 |
| 10 | signifcant | 4 |
| 11 | detected.the | 3 |
| 12 | treatment-by-aspects | 3 |
| 13 | mode-dependent | 2 |
| 14 | non-statistically-significant | 2 |
| 15 | region-wise | 2 |
| 16 | sedative-sparing | 2 |
| 17 | signifficant | 2 |
| 18 | variety-dependent | 2 |
| 19 | -1.229171 | 1 |
| 20 | 0.7-score | 1 |
| 21 | 1.00-point | 1 |
| 22 | 1.35°c | 1 |
| 23 | 17-nucleotide | 1 |
| 24 | 2-μv | 1 |
| 25 | 2.2-point | 1 |
| 26 | 2.7-point | 1 |
| 27 | 3-french | 1 |
| 28 | 40-cell/µl | 1 |
| 29 | 6-azido-1-benzyl-3- | 1 |
| 30 | 640kb | 1 |
| 31 | 71.9-mg | 1 |
| 32 | acurately | 1 |
| 33 | ai-specific | 1 |
| 34 | anti-analgesic | 1 |
| 35 | antinocieptive | 1 |
| 36 | antioxidat | 1 |
| 37 | betahistine-induced | 1 |
| 38 | between-subgroup | 1 |
| 39 | breed-dependent | 1 |
| 40 | calcifications/some | 1 |
| 41 | carry-over/period | 1 |
| 42 | circuit-related | 1 |
| 43 | country-by-treatment | 1 |
| 44 | cyp2c19-dependent | 1 |
| 45 | cyp450-based | 1 |
| 46 | df1-df2 | 1 |
| 47 | diet-dose | 1 |
| 48 | difference-in | 1 |
| 49 | different.confirmed | 1 |
| 50 | different.furthermore | 1 |
| 51 | divided-dose-ratg | 1 |
| 52 | dna-condensation | 1 |
| 53 | donor-specificity | 1 |
| 54 | etanercept-related | 1 |
| 55 | excuses/sin | 1 |
| 56 | frequencyxtime | 1 |
| 57 | gender-diet | 1 |
| 58 | gene-feeding-group | 1 |
| 59 | genotype-phenothype | 1 |
| 60 | group×genotype | 1 |
| 61 | hydroxycut-related | 1 |
| 62 | ignificant | 1 |
| 63 | ignificantly | 1 |
| 64 | inclusion-related | 1 |
| 65 | inter-complex | 1 |
| 66 | inter-county | 1 |
| 67 | interclade | 1 |
| 68 | intra/postpartum | 1 |
| 69 | kidney-mediated | 1 |
| 70 | localization-dependent | 1 |
| 71 | nonhyperventilation | 1 |
| 72 | one-degree | 1 |
| 73 | one-dilution | 1 |
| 74 | provable | 1 |
| 75 | qem | 1 |
| 76 | race-sbp | 1 |
| 77 | reportfor | 1 |
| 78 | rr=2.82 | 1 |
| 79 | rs5750146 | 1 |
| 80 | satistical | 1 |
| 81 | score-assessed | 1 |
| 82 | sepsis-only | 1 |
| 83 | ses-related | 1 |
| 84 | sex-gene | 1 |
| 85 | signi-ficant | 1 |
| 86 | signicant | 1 |
| 87 | signifant | 1 |
| 88 | significan | 1 |
| 89 | significane | 1 |
| 90 | significant-albeit | 1 |
| 91 | significant-or | 1 |
| 92 | significant-treatment | 1 |
| 93 | significant.non-fatal | 1 |
| 94 | significantl | 1 |
| 95 | signiticant | 1 |
| 96 | signuficant | 1 |
| 97 | singnificant | 1 |
| 98 | sober-to-drunk | 1 |
| 99 | specialty-related | 1 |
| 100 | tecarfarin-fluconazole | 1 |
| 101 | trans-pinocarveol | 1 |
| 102 | treatment-by-day | 1 |
| 103 | treatment-elicited | 1 |
| 104 | treg-dependent | 1 |
| 105 | vms-thyroid | 1 |
| 106 | wi-thout | 1 |
| 107 | winking | 1 |
| 108 | zgp | 1 |
| 109 | zolpidem-dependent | 1 |
| 110 | €257 | 1 |
| 1 | -1.229171 | 1 |
| 2 | 0.7-score | 1 |
| 3 | 1.00-point | 1 |
| 4 | 1.35°c | 1 |
| 5 | 17-nucleotide | 1 |
| 6 | 2-μv | 1 |
| 7 | 2.2-point | 1 |
| 8 | 2.7-point | 1 |
| 9 | 3-french | 1 |
| 10 | 40-cell/µl | 1 |
| 11 | 6-azido-1-benzyl-3- | 1 |
| 12 | 640kb | 1 |
| 13 | 71.9-mg | 1 |
| 14 | acurately | 1 |
| 15 | ai-specific | 1 |
| 16 | anti-analgesic | 1 |
| 17 | antinocieptive | 1 |
| 18 | antioxidat | 1 |
| 19 | betahistine-induced | 1 |
| 20 | between-subgroup | 1 |
| 21 | borderline-significant | 4 |
| 22 | breed-dependent | 1 |
| 23 | calcifications/some | 1 |
| 24 | carry-over/period | 1 |
| 25 | circuit-related | 1 |
| 26 | country-by-treatment | 1 |
| 27 | cyp2c19-dependent | 1 |
| 28 | cyp450-based | 1 |
| 29 | detected.the | 3 |
| 30 | df1-df2 | 1 |
| 31 | diet-dose | 1 |
| 32 | difference-in | 1 |
| 33 | different.confirmed | 1 |
| 34 | different.furthermore | 1 |
| 35 | discernable | 43 |
| 36 | divided-dose-ratg | 1 |
| 37 | dna-condensation | 1 |
| 38 | donor-specificity | 1 |
| 39 | doxycycline-mediated | 5 |
| 40 | etanercept-related | 1 |
| 41 | excuses/sin | 1 |
| 42 | frequencyxtime | 1 |
| 43 | gender-diet | 1 |
| 44 | gene-feeding-group | 1 |
| 45 | genotype-phenothype | 1 |
| 46 | genotype-related | 7 |
| 47 | group×genotype | 1 |
| 48 | hydroxycut-related | 1 |
| 49 | ignificant | 1 |
| 50 | ignificantly | 1 |
| 51 | inclusion-related | 1 |
| 52 | inter-complex | 1 |
| 53 | inter-county | 1 |
| 54 | interclade | 1 |
| 55 | intra/postpartum | 1 |
| 56 | kidney-mediated | 1 |
| 57 | localization-dependent | 1 |
| 58 | mode-dependent | 2 |
| 59 | non-statistically-significant | 2 |
| 60 | nonhyperventilation | 1 |
| 61 | one-degree | 1 |
| 62 | one-dilution | 1 |
| 63 | provable | 1 |
| 64 | qem | 1 |
| 65 | race-sbp | 1 |
| 66 | region-wise | 2 |
| 67 | reportfor | 1 |
| 68 | rr=2.82 | 1 |
| 69 | rs5750146 | 1 |
| 70 | satistical | 1 |
| 71 | score-assessed | 1 |
| 72 | sedative-sparing | 2 |
| 73 | sepsis-only | 1 |
| 74 | ses-related | 1 |
| 75 | sex-gene | 1 |
| 76 | sigificant | 4 |
| 77 | signficant | 9 |
| 78 | signi-ficant | 1 |
| 79 | signicant | 1 |
| 80 | signifant | 1 |
| 81 | signifcant | 4 |
| 82 | signifficant | 2 |
| 83 | significan | 1 |
| 84 | significane | 1 |
| 85 | significant | 154,178 |
| 86 | significant-albeit | 1 |
| 87 | significant-or | 1 |
| 88 | significant-treatment | 1 |
| 89 | significant.non-fatal | 1 |
| 90 | significantl | 1 |
| 91 | significative | 65 |
| 92 | signiticant | 1 |
| 93 | signuficant | 1 |
| 94 | singnificant | 1 |
| 95 | sober-to-drunk | 1 |
| 96 | specialty-related | 1 |
| 97 | statistically-significant | 30 |
| 98 | tecarfarin-fluconazole | 1 |
| 99 | trans-pinocarveol | 1 |
| 100 | treatment-by-aspects | 3 |
| 101 | treatment-by-day | 1 |
| 102 | treatment-elicited | 1 |
| 103 | treg-dependent | 1 |
| 104 | variety-dependent | 2 |
| 105 | vms-thyroid | 1 |
| 106 | wi-thout | 1 |
| 107 | winking | 1 |
| 108 | zgp | 1 |
| 109 | zolpidem-dependent | 1 |
| 110 | €257 | 1 |
| 1 | 6-azido-1-benzyl-3- | 1 |
| 2 | -1.229171 | 1 |
| 3 | rr=2.82 | 1 |
| 4 | df1-df2 | 1 |
| 5 | rs5750146 | 1 |
| 6 | €257 | 1 |
| 7 | 640kb | 1 |
| 8 | ai-specific | 1 |
| 9 | anti-analgesic | 1 |
| 10 | 1.35°c | 1 |
| 11 | betahistine-induced | 1 |
| 12 | different.confirmed | 1 |
| 13 | cyp450-based | 1 |
| 14 | score-assessed | 1 |
| 15 | doxycycline-mediated | 5 |
| 16 | kidney-mediated | 1 |
| 17 | genotype-related | 7 |
| 18 | inclusion-related | 1 |
| 19 | ses-related | 1 |
| 20 | circuit-related | 1 |
| 21 | etanercept-related | 1 |
| 22 | hydroxycut-related | 1 |
| 23 | specialty-related | 1 |
| 24 | treatment-elicited | 1 |
| 25 | vms-thyroid | 1 |
| 26 | carry-over/period | 1 |
| 27 | interclade | 1 |
| 28 | 17-nucleotide | 1 |
| 29 | one-degree | 1 |
| 30 | detected.the | 3 |
| 31 | discernable | 43 |
| 32 | provable | 1 |
| 33 | tecarfarin-fluconazole | 1 |
| 34 | frequencyxtime | 1 |
| 35 | calcifications/some | 1 |
| 36 | significane | 1 |
| 37 | sex-gene | 1 |
| 38 | genotype-phenothype | 1 |
| 39 | group×genotype | 1 |
| 40 | 0.7-score | 1 |
| 41 | different.furthermore | 1 |
| 42 | region-wise | 2 |
| 43 | diet-dose | 1 |
| 44 | significative | 65 |
| 45 | antinocieptive | 1 |
| 46 | 71.9-mg | 1 |
| 47 | winking | 1 |
| 48 | sedative-sparing | 2 |
| 49 | divided-dose-ratg | 1 |
| 50 | 3-french | 1 |
| 51 | sober-to-drunk | 1 |
| 52 | satistical | 1 |
| 53 | significant.non-fatal | 1 |
| 54 | trans-pinocarveol | 1 |
| 55 | significantl | 1 |
| 56 | 40-cell/µl | 1 |
| 57 | qem | 1 |
| 58 | intra/postpartum | 1 |
| 59 | significan | 1 |
| 60 | difference-in | 1 |
| 61 | excuses/sin | 1 |
| 62 | nonhyperventilation | 1 |
| 63 | dna-condensation | 1 |
| 64 | one-dilution | 1 |
| 65 | race-sbp | 1 |
| 66 | zgp | 1 |
| 67 | gene-feeding-group | 1 |
| 68 | between-subgroup | 1 |
| 69 | significant-or | 1 |
| 70 | reportfor | 1 |
| 71 | treatment-by-aspects | 3 |
| 72 | antioxidat | 1 |
| 73 | gender-diet | 1 |
| 74 | significant-albeit | 1 |
| 75 | signifcant | 4 |
| 76 | signi-ficant | 1 |
| 77 | signifficant | 2 |
| 78 | sigificant | 4 |
| 79 | ignificant | 1 |
| 80 | significant | 154,178 |
| 81 | borderline-significant | 4 |
| 82 | statistically-significant | 30 |
| 83 | non-statistically-significant | 2 |
| 84 | singnificant | 1 |
| 85 | signficant | 9 |
| 86 | signuficant | 1 |
| 87 | signicant | 1 |
| 88 | signiticant | 1 |
| 89 | signifant | 1 |
| 90 | cyp2c19-dependent | 1 |
| 91 | breed-dependent | 1 |
| 92 | mode-dependent | 2 |
| 93 | treg-dependent | 1 |
| 94 | zolpidem-dependent | 1 |
| 95 | localization-dependent | 1 |
| 96 | variety-dependent | 2 |
| 97 | significant-treatment | 1 |
| 98 | country-by-treatment | 1 |
| 99 | 1.00-point | 1 |
| 100 | 2.2-point | 1 |
| 101 | 2.7-point | 1 |
| 102 | wi-thout | 1 |
| 103 | 2-μv | 1 |
| 104 | inter-complex | 1 |
| 105 | treatment-by-day | 1 |
| 106 | acurately | 1 |
| 107 | sepsis-only | 1 |
| 108 | ignificantly | 1 |
| 109 | donor-specificity | 1 |
| 110 | inter-county | 1 |